CDK1 and non-small cell lung carcinoma: Cyclin B1 (in the same family as CDK1) overexpression and/or mislocalisation has been described in several primary cancers, including thyroid carcinoma and colon, gastric, prostate, breast, and non small-cell lung cancers [44].